Skip to main content

ADVERTISEMENT

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Clinical Pathways GPS
09/19/2017
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Clinical pathways most often guide treatment decisions based on a diagnosis, but what about assistance for directing where and when care is most effectively rendered? Improving clinical and financial outcomes...
Clinical pathways most often guide treatment decisions based on a diagnosis, but what about assistance for directing where and when care is most effectively rendered? Improving clinical and financial outcomes...
...
09/19/2017
Journal of Clinical Pathways
Clinical Pathways GPS
08/16/2017
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Scott Guerin, PhD
For clinical pathways to be most effective, they need to accommodate many external factors impacting patients. These include issues such as the social determinants of health, as well as access to care that can impact...
For clinical pathways to be most effective, they need to accommodate many external factors impacting patients. These include issues such as the social determinants of health, as well as access to care that can impact...
For...
08/16/2017
Journal of Clinical Pathways
Clinical Pathways GPS
06/14/2017
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Scott Guerin, PhD
President Donald J Trump’s selection of Scott Gottlieb, MD, to lead the Food and Drug Administration (FDA) has ushered in a new direction for the government agency, which is likely to alter the availability and use...
President Donald J Trump’s selection of Scott Gottlieb, MD, to lead the Food and Drug Administration (FDA) has ushered in a new direction for the government agency, which is likely to alter the availability and use...
...
06/14/2017
Journal of Clinical Pathways
Clinical Pathways GPS
05/12/2017
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Over the course of the Trump Administration’s first 100 days, the president and members of Congress have introduced health care reform legislation that aims to profoundly change the ways medicine is practiced—and...
Over the course of the Trump Administration’s first 100 days, the president and members of Congress have introduced health care reform legislation that aims to profoundly change the ways medicine is practiced—and...
Over...
05/12/2017
Journal of Clinical Pathways
Clinical Pathways GPS
04/11/2017
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Sevy Gambs, MBA, ALA, MSN-GR
Older adults are at risk for a host of potential medical issues while traveling, arising from cognitive impairments such as Alzheimer disease, dementia or psychiatric disorders, and chronic conditions such as...
Older adults are at risk for a host of potential medical issues while traveling, arising from cognitive impairments such as Alzheimer disease, dementia or psychiatric disorders, and chronic conditions such as...
Older...
04/11/2017
Journal of Clinical Pathways
Clinical Pathways GPS
03/15/2017
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Terri L Schieder, RN, MS, MBA
Clinical pathways should address all three aspects of the Triple Aim, but the aim of improving population health often is prioritized at the expense of improving the patient experience of care and reducing the cost...
Clinical pathways should address all three aspects of the Triple Aim, but the aim of improving population health often is prioritized at the expense of improving the patient experience of care and reducing the cost...
...
03/15/2017
Journal of Clinical Pathways
Clinical Pathways GPS
12/13/2016
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Aysha Khan, MD
Nader Tavakoli, MD, CMD, FAAFP
Multiple sclerosis (MS) is a disabling condition that is managed medically through an ever growing list of pharmaceutical treatments. Clinical pathways that focus primarily on treatments for the disease overlook...
Multiple sclerosis (MS) is a disabling condition that is managed medically through an ever growing list of pharmaceutical treatments. Clinical pathways that focus primarily on treatments for the disease overlook...
...
12/13/2016
Journal of Clinical Pathways
Clinical Pathways GPS
11/15/2016
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
As our health system increases the financial responsibility of health care providers, there is increased focus among these providers on reducing costs. Part of this cost-reduction effort involves improving the...
As our health system increases the financial responsibility of health care providers, there is increased focus among these providers on reducing costs. Part of this cost-reduction effort involves improving the...
As our...
11/15/2016
Journal of Clinical Pathways
Clinical Pathways GPS
05/06/2016
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Scott Guerin, PhD
Seth Gordon, MBA
The concept of the Triple Aim—improving the experience of care, reducing the costs of care, and improving the health of populations—is increasingly becoming important to drug manufacturers, who must demonstrate how...
The concept of the Triple Aim—improving the experience of care, reducing the costs of care, and improving the health of populations—is increasingly becoming important to drug manufacturers, who must demonstrate how...
The...
05/06/2016
Journal of Clinical Pathways
Clinical Pathways GPS
04/11/2016
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Harold Freeman, MD
Ruth Gay
Mary Michael
David Digby
Patient navigation has proven capable of both improving health outcomes and decreasing costs to the health care system. Although the use of patient navigation in the context of cancer care has been described...
Patient navigation has proven capable of both improving health outcomes and decreasing costs to the health care system. Although the use of patient navigation in the context of cancer care has been described...
...
04/11/2016
Journal of Clinical Pathways